Alluvi Retatrutide BPC-157 & TB-500 40mg Premium Research-Grade Peptide Blend The Alluvi Retatrutide BPC-157 & TB-500 40mg is a premium research-grade peptide blend developed for scientific, educational, and laboratory research applications
Seek emergency care if you have difficulty breathing, throat/face swelling, fainting, high fever, intense abdominal pain, dark urine, or yellowing of skin/eyes
June 2026 Update: OROS has begun rolling out USP Residual Solvent Analysis on all newly manufactured batches, screening for trace residual solvents including Acetonitrile, Methanol, DMF, and Dichloromethane as part of our continued commitment to comprehensive batch-level quality control
Study 7: REDEFINE 3, cardiovascular outcome trial (ongoing) Citation: NCT05669755, REDEFINE 3 Phase 3 trial